Artificial Intelligence

Bausch + Lomb beats Q4 revenue forecasts, propelled by its blockbuster dry eye drug MIEBO, and issues a confident financial outlook for 2026.

Upwork announces a new $300M share buyback, signaling deep confidence in its AI strategy and financial health as it aims to redefine the future of work.

AI firm Docebo's $60M share buyback is complicated by its majority owner's surprise move and new debt, sparking questions about its strategy.

A new service offers active human management for your 401(k), promising higher returns. But does the personal touch justify the potential cost?

AcuityMD's new Salesforce integration promises to eliminate data silos and boost sales for MedTech firms, marking a strategic leap for the AI unicorn.

A new AI-native system, Isaac PracticeOS, promises to replace up to ten dental software tools, automating claims, scheduling, and patient communications.

As AI risks grow, companies like Cycore are racing to offer unified compliance solutions for a complex and costly web of new global regulations.

Hyliion's fuel-agnostic generator runs on diesel, meeting tough emission rules without add-ons and unlocking resilient power for defense and data centers.

The bitcoin financial services firm is now a CFTC-registered Commodity Trading Advisor, a move signaling a new era of compliance for institutional crypto.

Riding a wave of innovation and strategic shifts, the cruise wellness leader posts record earnings and projects over $1B in 2026 revenue.

A new biotech emerges with massive funding and a next-gen 'shuttle' to deliver safer, more effective Alzheimer's therapies directly to the brain.

After being silenced by extremists, the Islam-inspired superhero team THE 99 returns with a $5M boost to bring its message of tolerance to 99+ countries.

Investment in Canadian fintech moderated to $2.4B in 2025, but a closer look reveals a healthy shift toward strategic AI and digital asset deals.

As agentic AI adoption accelerates, Cloud Range's new platform offers a secure environment for organizations to test and validate AI models before deployment.

A new report reveals retail traders are abandoning anonymous forums for platforms with audited data, professionalizing the meme stock era for good.

Tech services firm Endava is integrating Cognition's AI coder, Devin, to help enterprises adopt agentic AI without sacrificing safety or control.

A breakthrough cell line shows a two-fold increase in viral vector quality, a key step in making gene therapies more effective, safer, and accessible.

comforte AG and ITSS Global launch a joint solution using tokenization to help banks secure PII and enable AI while ensuring compliance.

Positive early trial data for ZP9830 shows promise for a new class of targeted autoimmune therapies, marking a strategic pivot for Zealand Pharma.

Photocure reports robust Q4 earnings and a strong 2026 forecast, while pivoting to an AI-driven future for bladder cancer diagnostics and global expansion.